Literature DB >> 30072505

Weight loss as a predictor of mortality in patients with interstitial lung disease.

Janelle Pugashetti1, Julia Graham1, Noelle Boctor1, Cesar Mendez2, Elena Foster2, Maya Juarez2, Richart Harper2, Brian Morrissey2, Michael Kadoch3, Justin M Oldham2.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30072505      PMCID： PMC6643265          DOI： 10.1183/13993003.01289-2018

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  10 in total

1.  Current Beliefs and Practices Regarding the Management of Obesity in Patients with Progressive Interstitial Lung Disease.

Authors:  Michaela R Anderson; Kerri I Aronson; Joshua M Diamond; Jason D Christie; Jonathan P Singer
Journal:  Ann Am Thorac Soc       Date:  2022-04-15

2.  Role of Krebs von den Lungen-6 (KL-6) in Assessing Hypersensitivity Pneumonitis.

Authors:  Amira Ismail Mostafa; Ayman Elsayed Salem; Heba Allah Moussa Ahmed; Aml Ibrahim Bayoumi; Radwa M Abdel Halim; Rasha M Abdel Samie
Journal:  Tuberc Respir Dis (Seoul)       Date:  2021-04-06

Review 3.  Nutrition in Patients with Idiopathic Pulmonary Fibrosis: Critical Issues Analysis and Future Research Directions.

Authors:  Paola Faverio; Marialuisa Bocchino; Antonella Caminati; Alessia Fumagalli; Monica Gasbarra; Paola Iovino; Alessandra Petruzzi; Luca Scalfi; Alfredo Sebastiani; Anna Agnese Stanziola; Alessandro Sanduzzi
Journal:  Nutrients       Date:  2020-04-17       Impact factor: 5.717

4.  In-hospital mortality trends among patients with idiopathic pulmonary fibrosis in the United States between 2013-2017: a comparison of academic and non-academic programs.

Authors:  Shehabaldin Alqalyoobi; Evans R Fernández Pérez; Justin M Oldham
Journal:  BMC Pulm Med       Date:  2020-11-07       Impact factor: 3.317

5.  Determinants of health-related quality of life decline in interstitial lung disease.

Authors:  Phillen Nozibuyiso Maqhuzu; Boglarka L Szentes; Michael Kreuter; Thomas Bahmer; Nicolas Kahn; Martin Claussen; Rolf Holle; Larissa Schwarzkopf
Journal:  Health Qual Life Outcomes       Date:  2020-10-08       Impact factor: 3.186

6.  Nutritional status and quality of life in interstitial lung disease: a prospective cohort study.

Authors:  Alisar A Kanjrawi; Lara Mathers; Susanne Webster; Tamera J Corte; Sharon Carey
Journal:  BMC Pulm Med       Date:  2021-02-05       Impact factor: 3.317

7.  Impact of body weight change on clinical outcomes in patients with idiopathic pulmonary fibrosis receiving pirfenidone.

Authors:  Tae Hun Kim; Yune-Young Shin; Hyung-Jun Kim; Myung Jin Song; Yeon Wook Kim; Sung Yoon Lim; Yeon Joo Lee; Jong Sun Park; Young-Jae Cho; Jae Ho Lee; Choon-Taek Lee; Byoung Soo Kwon
Journal:  Sci Rep       Date:  2022-10-17       Impact factor: 4.996

8.  Decrements of body mass index are associated with poor outcomes of idiopathic pulmonary fibrosis patients.

Authors:  Tejaswini Kulkarni; Kaiyu Yuan; Thi K Tran-Nguyen; Young-Il Kim; Joao A de Andrade; Tracy Luckhardt; Vincent G Valentine; Daniel J Kass; Steven R Duncan
Journal:  PLoS One       Date:  2019-10-04       Impact factor: 3.240

9.  Impact of progressive fibrosing interstitial lung disease (ILD) in ILD patients complicated with secondary spontaneous pneumothorax.

Authors:  Hideaki Yamakawa; Yuta Tsukahara; Shintaro Sato; Hiroki Ohta; Gen Kida; Tomohiko Nakamura; Tomotaka Nishizawa; Rie Kawabe; Tomohiro Oba; Keiichi Akasaka; Masako Amano; Kazuyoshi Kuwano; Hiroki Sasaki; Tamiko Takemura; Hidekazu Matsushima
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2022-01-13       Impact factor: 0.670

10.  Associations of Serum Adipokines With Subclinical Interstitial Lung Disease Among Community-Dwelling Adults: The Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  John S Kim; Michaela R Anderson; Anna J Podolanczuk; Steven M Kawut; Matthew A Allison; Ganesh Raghu; Karen Hinckley-Stuckovsky; Eric A Hoffman; Russell P Tracy; R Graham Barr; David J Lederer; Jon T Giles
Journal:  Chest       Date:  2019-10-31       Impact factor: 9.410
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.